GlaxoSmithKline, Sanford Burnham launch neuroscience hub

Sanford Burnham Prebys Medical Discovery Institute and London’s GlaxoSmithKline ($GSK) have teamed up to launch a new “SBP-GSK Center for Translational Neuroscience.” The new Center, located on the medical research Institute’s campus in La Jolla, California, will bring together staff from Sanford Burnham and GSK to investigate factors that influence brain function and potentially reverse or slow down neurodegeneration–such as that seen in dementia–with the ultimate aim of finding new drug targets. The two already have history, as SBP’s CEO Perry Nisen used to be senior VP of science and innovation at GSK. Nisen’s move in 2014 was in fact the start of the Institute’s new strategy to become the “partner of choice” for drugmakers as it looks to move more deeply in drug discovery. It has also in the…


Link to Full Article: GlaxoSmithKline, Sanford Burnham launch neuroscience hub